( Oregon Health & Science University ) Nearly 20 percent of people who underwent low back fusion surgery developed post-traumatic stress disorder symptoms associated with that surgery, according to a recent Oregon Health & Science University study publ…

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that it has amended and expanded the scope of the protocol PV-10-LC-01, "A Phase 1 Study to Assess the Safety, Tolerability and Phar…

NEWARK, Calif. — StemCells, Inc. today announced that the first patient with an incomplete spinal cord injury has been enrolled in the Company's Phase I/II clinical trial in chronic spinal cord injury …

Provectus Pharmaceuticals, Inc. , a development-stage oncology and dermatology biopharmaceutical company, announced that it has amended and expan

SIU doctor seeks answers for why organs often fail after 15 years. 

After surviving a near-fatal car accident, Kaitlin Hunter found herself battling a devastating bacterial infection in her colon that also threatened her life.

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , today announced the completion of patient enrollment in a phase III clinical trial of ADCETRIS for post-transplant …

Blood donors are being invited to take part in a study which could shape the future of blood donation nationally and internationally, providing a personalised service for donors.

RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2012 /PRNewswire/ — Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced data highlighting the significant …

The grossness notwithstanding, people would likely agree to undergo a fecal transplant if they were suffering from persistent C. difficile diarrhea, a new study suggests.